Brooks Udelsman

Trauma surgeons often need to act on CT scans before a formal read is available. This commentary reviews evidence showing surgeons interpret CTs accurately and argues they should routinely review images in real time while collaborating with radiology. journals.lww.com/annalsofsurger…

US nonprofit hospitals spent $7.8 billion on management consultants from 2009 to 2023, but contracts were not associated with meaningful changes in finance, operations, or quality of care. 🧵 ja.ma/4d46zfq

In shocking news, watching “death by PowerPoint” training modules is not as useful as everyone in healthcare administration thinks.

We are so excited to welcome you to the inaugural ThORN Annual Meeting on May 1st from 3:00-5:45pm in Chicago, IL!!  Registration is free and open to anyone interested in thoracic surgery! Sign up now at thornsurgery.org/conference!   #AATS2026

Yes!! I feel seen. My all-time favorite punctuation is now an AI tell — so disappointing.

Dr. J.P. Wilson taught me this in 1998 as I began my general surgery residency… I still sit or kneel at the bedside when I round. It takes me longer to get up, but allowing them to look low into my eyes as we speak is important for both me and them. Glad to see the data.

Preoperative circulating tumor DNA (#ctDNA) detection in early-stage esophageal squamous cell carcinoma was associated with nodal metastasis and poorer survival, supporting its use for risk stratification. ja.ma/4kELqfa

Congratulations to the 2026 WTS-STS Scholarship Program recipients! We hope you had an educational and inspiring experience at the STS 62nd Annual Meeting in New Orleans, LA #STS2026.   Thank you to STS @STS_CTsurgery for your continued support of this program and #WTS.

The proportion of NSCLC diagnosed as stage I is soaring in the VA while it is only barely rising in other healthcare systems across the US. If all insurance systems achieved the unadjusted stage distribution seen in the VA, an additional 45,684 pts would be diagnosed with stage I and 65,933 fewer stage IV. [Data reported by the St Louis VA thoracic surgery research team in 2024] @VAResearch doi.org/10.1016/j.atho…

Thanks @JNCCN for publishing our work, the first author and our primary workhorse @TanPoHong2, and our group at large for making this work possible. @ThielsCA @KPoruk_MD @HorHoeYan @Chee_CheeStucky @DrRickBold @TELL_Starlinger @johnstauffer

Thanks to the LA Times for continuing to report on everyone who (a) caused the LA fires thru sheer incompetence/stupidity, (b) had no real plan for stopping the fires, and/or (c) tried to cover up their own mistakes/liability afterwards. What a disgrace. latimes.com/california/sto…

Great presentation by Shefali Varma, using novel methodology to explain differences in outcomes for sublobar resection in retrospective databases and RCTs

Congratulations Cat Dugan on opening ASC with a great presentation! Social readmissions are a costly and preventable source of morbidity for our lung transplant patients #ASC2026 @uscsurgery

#ThORN is proud to have a strong presence at #STS2026! 🫁 33 members presenting 🎤 9 session chairs 📊 61 total presentations We look forward to seeing you there! #TSSMN #MedEd #SurgTwitter #AcademicTwitter ⬇️ Full schedule below ⬇️

Please take a few minutes to read this moving story by @SimarSBajaj in @nytimes about the soul-crushing weight of stigma that so many people with lung cancer carry every day. I was nearly in tears reading it. We must do a better job of destigmatizing lung cancer. No patient should ever be made to feel this alone. I also want to express my deepest gratitude to Ms. Cottrill, Ms. Padua-Reyes, and Mr. Pantelas for sharing your stories. I am profoundly grateful for your courage in opening up about such deeply personal experiences—your voices matter, and they are changing lives. Link: nytimes.com/2026/01/14/wel…

Viewpoint: #MandM conferences benefit surgeon moral development by fostering personal responsibility, reflection, and a mindset for improvement in #Surgery. @pangelos1 @seancwightman ja.ma/48M12rL

It’s problematic to define complication severity by return to OR or need for gen anes. Doing so risks creating inappropriate avoidance of returning to OR. Furthermore it simply makes no sense. Severity should not be defined by how we fix the complication, but rather how it impacts the patient!

The life cycle of an academic manuscript: ✒️FinalDraft.docx ✒️FinalDraft2.docx ✒️FinalDraft2_REAL.docx ✒️FinalDraft2_REAL_FINAL.docx ✒️FinalDraft2_REAL_FINAL_v2.docx 📝FINAL_FINAL_DRAFT_THIS_ONE.docx And after all that: Maybe I should rewrite the introduction...🤔

@irbaz_hameed @yalectsurgery Congrats Irbaz! So interesting

In #Nature Bioeng, we discuss the biological mechanisms of cellular injury, perfusate modifications and mechanistic approaches for reinstating circulation. go.nature.com/4kJAtJ1

~13yrs of neoadjuvant adventure comes to positive conclusion (for now)! In @NEJM today & presented at #ASCO25 5 yr survival for pts w lung cancer that can be removed by surgery is better with just 3 doses of immunotherapy before the operation! nejm.org/doi/full/10.10… #LCSM 1/